This is a firm fixed price contract for development of modernized susceptibility guidance for ampicillin and vancomycin for enterococcus species using pharmacometric approaches
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40123C00140
- Awardee
-
Institute For Clinical Pharmacodynamics, Inc. UEI Z82HHPY83MC7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $263,016
Award facts
- Contract value 100% obligated
- $263,016.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Two Step
- Pricing
- Firm Fixed Price
- Place of performance
- Schenectady, NY 12305, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Original award | $263,016 |
About this award
This is a firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Institute For Clinical Pharmacodynamics, Inc., a minority-owned, for-profit organization based in Schenectady, New York. The contract, valued at $263,016.10, is for the development of modernized susceptibility guidance for the antibiotics ampicillin and vancomycin for Enterococcus species using pharmacometric approaches. The contract has a period of performance ending on March 29, 2025. This contract is not associated with a set-aside designation. The company has been awarded multiple prime contracts from the FDA, focused on developing modernized scientific guidance and conducting specialized research in pharmaceuticals and infectious disease modeling to support the agency's efforts to combat antibiotic-resistant bacteria and improve clinical treatment guidelines.
Quick answers
Who was awarded contract 75F40123C00140?
75F40123C00140 was awarded to Institute For Clinical Pharmacodynamics, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 18, 2023.
How much is contract 75F40123C00140 worth?
The government has obligated $263,016 on 75F40123C00140.
Was contract 75F40123C00140 competed?
The extent of competition for 75F40123C00140 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award